News
-
Europe biosimilar tick
Tuesday | Jun 20 2017THE European Commission has approved Sandoz' rituximab biosimilar Rixathon (also approved as Riximyo), for treatment of blood cancers and immunological diseases, according to an announcement from Sandoz' parent company Novartis.
-
Get ready for RUM
Tuesday | Jun 20 2017RETURN Unwanted Medicines (RUM) has announced a new "READ, REMOVE & RETURN" consumer campaign, and alerts pharmacists across the country to prepare for increased collection volumes of unwanted medicines.
-
Oct disclosure cycle
Tuesday | Jun 20 2017THE Department of Health has posted Price Disclosure Reductions for the 2017 Oct Cycle on the Pharmaceutical Benefits Scheme (PBS) website.
-
Guild drives 6CPA
Tuesday | Jun 20 2017NATIONAL president of the Pharmacy Guild of Australia George Tambassis has acknowledged Guild members' desire to hear about progress in the allocation of the $600 million in the Sixth Community Services Agreement (6CPA) for new and existing community pharmacy programs.
-
Injectables Handbook
Tuesday | Jun 20 2017THE Society of Hospital Pharmacists of Australia (SHPA) has announced the release of the 7th edition of the Australian Injectable Drugs Handbook (AIDH).
-
Check-list saves errors
Tuesday | Jun 20 2017THE introduction of a discharge medication checklist demonstrated a significant reduction in errors in hospital discharge prescription assembly by nurses, according to a study by three senior pharmacists based at King's College Hospital NHS Foundation Trust, London.
-
Hospira NaHCO3 recall
Tuesday | Jun 20 2017PFIZER offshoot Hospira has confirmed a voluntary recall in the US of 47 lots of sodium bicarbonate injection and other injectables to the hospital/retail level, upon fears of microbial contamination.
-
Blackmores to advise China
Tuesday | Jun 20 2017AUSTRALIAN-LISTED natural health company Blackmores has been named to take a key leadership advisory role for the China Association for Quality Inspection (CAQI), a "high level non-profit Chinese organisation with responsibility for product quality inspection".
-
Medlab cannabis studies
Tuesday | Jun 20 2017AUSTRALIAN-LISTED Medical life science company, Medlab Clinical Limited, has announced it has received Human Research Ethics Committee approvals by the Northern Sydney Local District, the Kolling Institute of Medical Research, Royal North Shore Hospital, to begin human trials of two different patent pending cannabis-based medicines.
-
